Fulcrum Therapeutics, Inc.FULCNASDAQ
Loading
Cash & Equivalents Over TimeExpanding
Percentile Rank100
3Y CAGR+77.9%
5Y CAGR+28.2%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
+77.9%/yr
vs -16.7%/yr prior
5Y CAGR
+28.2%/yr
Recent acceleration
Acceleration
+94.5pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
3.5x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $197.53M | +239.3% |
| 2024 | $58.21M | +127.7% |
| 2023 | $25.56M | -27.2% |
| 2022 | $35.10M | -0.9% |
| 2021 | $35.41M | -37.9% |
| 2020 | $57.05M | -41.0% |
| 2019 | $96.71M | +32.9% |
| 2018 | $72.80M | +17786.2% |
| 2017 | $407000.00 | - |